Clinical Trial on Hospitalized Children Suffering from Lead Poisoning Reveals the Safety and Effectiveness of Modified Citrus Pectin (MCP)

Santa Rosa, CA - July 21, 2008 - EcoNugenics announces the results of a collaborative study with the U.S. Department of Agriculture (USDA), Agricultural Research Service (ARS) that reveals the effectiveness and safety of modified citrus pectin (MCP; PectaSol) in dramatically lowering lead toxicity in children who were suffering from severe lead poisoning. The study was conducted with kids between the ages of five and twelve years old at the Department of Medicine, Children's Hospital, Zhejiang University School of Medicine, Republic of China. It was published in the current July/August issue of Alternative Therapies and Health Medicine, a peer reviewed journal.

"We are very excited about demonstrating the effectiveness of MCP," said principal investigator, Isaac Eliaz, M.D., L.Ac., M.S. "Children are most vulnerable to the long lasting health effects of lead exposure and now there is a safe way to address a very dangerous condition. This study lays the foundation for resolving a global health issue."

Environmental scientists and health practitioners, worldwide, have had an ongoing concern about lead toxicity and children. The industry has searched far and wide for a gentle safe heavy metal chelating agent, especially for kids with high environmental chronic exposure. This study reveals that there is finally a safe, natural and effective way to address this global issue. Increased public awareness has helped reduce the prevalence of lead poisoning in the United States, but the Centers for Disease Control and Prevention estimate that about 310,000 children below the age of five have higher-than-desirable blood lead levels in our country, alone.

About EcoNugenics
Dr. Eliaz founded EcoNugenics, Inc. in 1995 with a commitment to offering dietary supplements and nutraceuticals based on the best of modern science integrated with the ancient wisdom of traditional and complementary therapies. EcoNugenics is committed to five basic principles, which include innovation in product formulation, thorough scientific research, ongoing clinical validation, customer education, empowerment and superior quality control. www.econugenics.com. A free report on chelation can be downloaded at www.betterhealthpublishing.org/chelationreport.